Abstract
Since the thyroid gland is one of the organs most affected by autoimmune processes, many patients with thyroiditis of Hashimoto (TH) seek medical advice on lifestyle variance and dietary modifications to improve and maintain their hyroid function. In this review, we aim to present and discuss some challenges associated with the nutritional management of TH, focusing on environmental and dietary deficits, inflammatory and toxic nutrients, cyanotoxins, etc. We discuss the relationships among different diets, chronic inflammation, and microbiota, and their impact on the development and exacerbation of TH in detail. We share some novel insights into the role of vitamin D and melatonin for preserving thyroid function during chronic inflammation in autoimmune predisposed subjects. A comprehensive overview is provided on anti-inflammatory nutrients and ecological diets, including foods for cleansing and detoxification, which represent strategies to prevent relapses and achieve overall improvement of life quality. In conclusion, data from biomedical and clinical studies provide evidence that an appropriate dietary and lighting regimen could significantly improve the function of the thyroid gland and reduce the reactivity of autoantibodies in TH. Compliance with nutritional guidelines may help TH patients to reduce the need for medicines.
1. Introduction
The thyroid gland is the organ most affected by autoimmune processes []. Between 20% and 40% of American Caucasians and British citizens show lymphocytic infiltration in post-mortem specimens, while the highest percentage is typical for white females []. The intra-thyroidal lymphocytic infiltration induces chronic inflammation and autoimmune conditions, which most often results in autoimmune hypothyroidism or thyroiditis of Hashimoto (TH) []. TH development leads to scarring and destruction of the thyroid gland and is manifested by by a decrease of plasma free triiodothyronine (T3) and thyroxine (T4), elevated plasma levels of thyroid-stimulating hormone (TSH) and by the presence of antibodies to thyroid peroxidase (Ab-TPO) and thyroglobulin (Ab-Tg) []. It is generally accepted that the pathogenesis of TH, like other autoimmune diseases, represents the combination of environmental (i.e., lighting regimen, pollution, micronutrients, variety of physical and social factors), existential (lifestyle, hormonal status, diet, gut microbiota), as well as genetic factors that provoke immunological dysfunction and support the autoimmune destruction of the gland [].
To treat the condition in the long term, patients with TH-associated hypothyroidism often require lifetime hormone replacement therapy with levothyroxine [,]. There is growing evidence of the existence of a thyroid–gut axis that controls many autoimmune disorders, and patients frequently report changes in their quality of life and thyroid function as a result of dietary modifications.
Genetic factors contribute to 70–80% of autoimmune thyroid diseases []. The major histocompatibility complex genes (HLA class I and II), thyroid-related genes, genes associated with thyroid peroxidase antibody synthesis (BACH2, TPO), and genes regulating immune response (CD40, CTLA4, PD1) are the common genetic factors [,].
From the environmental factors, a vast variety of nutrients play an important role in the onset and development of TH. High iodine intake, deficiencies of selenium and iron, inadequate intake of proteins, unsaturated fatty acids, and dietary fibers could favor TH [,,]. Proinflammatory foods may induce dysbiosis and oxidative stress [] that can cause intestinal inflammation and spread it towards different organs, including the thyroid gland [,,]. The reduction and replacement of commensal microbiota caused by dietary supplementation significantly change the immune function and epithelial metabolism of the intestinal mucosa and the absorption of nutrients [,]. Drugs such as pembrolizumab, interferon-α, anti-retroviral therapy, and estrogens used for oral contraception or hormone replacement therapy are also crucial for TH [,]. Smoking and moderate alcohol consumption protect against TH, but quitting smoking may provoke this disease []. Immunomodulatory therapies and infections such as rubella, hepatitis C, and Epstein-Barr virus could also be responsible for the development of TH [].
Cyanotoxins such as cylindrospermopsin (CYN) and microcystins, in addition to their general toxicity, increase the permeability of epithelial and model pseudo-epithelial layers of human intestines. They even possess the ability to affect the function of the gastrointestinal epithelium and other cell types, and thus induce “leaky gut” syndrome, inflammation, oxidative stress, and apoptosis []. Furthermore, microcystins dose-dependently reduce thyroid hormone levels, and influence deiodinase activity and transcription of genes related to thyroid hormones’ synthesis and metabolism []. Direct harmful effects of acute and chronic exposure to cyanotoxins on the hypothalamic–pituitary–thyroid (HPT) axis may lead to hypothyroidism [,].
Individual characteristics such as age, lifestyle, gender, pregnancy, and certain diseases, such as allergic rhinitis, prolactinoma, and subacute thyroiditis, may serve as an important predisposition or triggers for TH [,]. Current treatment of TH in hypothyroid subjects includes replacement monotherapy with levothyroxine, which greatly reduces relapses of the disease and slows down the progression of thyroid damage. However, a proportion of the patients continue to experience various symptoms and deteriorating overall quality of life. Unfortunately, there are limited data on any effective concomitant treatment other than levothyroxine, which by itself does not target the autoimmune processes related to disease severity. It is already known that the diet and lifestyle of patients with TH can play a key role in the management of disease episodes, which necessitates an in-depth study of complex external and internal factors. Intensive research shows that many dietary supplements have the potential to positively affect TH symptomatology due to their anti-inflammatory and antidepressant activity, thus improving the overall sense of well-being. Among the most attractive candidates which may be able to influence the severity of clinical symptoms and improve thyroid function are vitamins from the groups A, B, C, and D, fatty acids, antioxidants, phytochemicals, but also the indole-amine melatonin [,].
The interest in dietary vitamin D and melatonin is based on research findings of their physiological role as regulators of the production of inflammatory cytokines and prostaglandins. The controlled dietary supplementation of vitamin D and melatonin might represent an essential strategy for treating TH via their molecular mechanisms on the cellular level. Data suggest that appropriate nutritional protocols may help to decrease the chronic inflammation in the thyroid gland, other tissues, and organs, as well as to suppress or stop the thyroid gland degradation and thus improve patients’ quality of life [,].
In this review, we aim to present and discuss challenges associated with the nutritional management of TH, focusing on environmental factors and dietary deficits, inflammatory and toxic nutrients, cyanotoxins, etc. We analyze the relationships between different diets, chronic inflammation, and microbiota, and their impact on the development and exacerbation of TH in detail. We share some novel insights into the roles of vitamin D and melatonin for preserving thyroid function during chronic inflammation in autoimmune predisposed individuals.
2. Nutritional Factors Linked to TH Etiopathogenesis
2.1. Nutritional Deficits or Excess
The nutritional deficit or excess of some minerals and other nutrients plays an essential role in the etiopathogenesis of hypothyroidism and TH []. Iron and selenium participate in T3 (active hormone) and T4 (prohormone) formation, where iodine is a part of these molecules, and selenium is a cofactor of deiodinases that activates T4 by converting it into T3 or inactivates both T4 and T3 []. Zinc is important for T3 receptor activation and can influence thyroid function via other mechanisms [,]. Reduced intake of some nutrients, such as vitamins (A, B1, B5, B6, and C), proteins, and minerals (magnesium, sodium, potassium, phosphorus, chromium), may also provoke or support TH, and this is more evident in deficiencies for more than one of these nutrients []. Adequate intake of A, C, and E vitamins and group B is recommended in prophylaxis and prevention of thyroid diseases because of their antioxidative (for vitamins C and E), anti-neoplastic, and anti-goitrogenic protection (for vitamins A, D, and E), as well as regulation of the pituitary–thyroid axis, the iodine intake in the thyroid gland, and T3 signaling (for vitamin A) [,,]. Inositol and its most abundant metabolite myo-inositol have a protective effect on the thyroid gland by improving TSH signaling and proinflammatory cytokine suppression [].
Some of the nutritional deficits typical for TH are presented in Table 1.
Table 1.
Deficits or excess of nutrients and their effects on thyroid gland function.
2.2. Nutritional Elements Generating Intoxication
Some trace elements such as Se, Zn, and Fe participate in thyroid gland function, and their deficiency is critical for thyroid hormone homeostasis (Table 1). Others such as lead, cadmium, chromium, manganese, and fluoride are toxic for many organs and tissues, including the thyroid gland, and may provoke or support hypothyroidism when their levels in the circulation are in excess [,].
Table 2 summarizes the common harmful effects of toxic trace elements on thyroid hormones’ synthesis and regulation.
Table 2.
Toxic nutritional elements.
2.3. Cyanotoxins and Thyroid Function
Cyanotoxins are a diverse group of toxins produced by cyanobacteria. Their amount increases exponentially during cyanobacteria bloom in sweet or salt waters. In this case, their poisonous substances achieve high concentrations that are sufficient to harm or even kill animals and humans [,]. Cyanotoxins microcystins, CYN, and lipopolysaccharides were linked to gastrointestinal complaints and effects on the immune system, including gastrointestinal inflammation []. Microcystin significantly alters the mouse gut microbiome and induces dysbiosis []. Microcystins are potent and specific inhibitors of protein phosphatases 1 and 2 A and can induce oxidative stress []. CYN can also lead to oxidative stress, either directly or indirectly linked to the reduction of glutathione formation []. Furthermore, CYN may reduce the viability of human gastrointestinal epithelial cells in culture and increases the permeability of intestinal epithelium [,]. Cyanotoxins are also shown to facilitate the absorption of other toxins due to their inflammatory action on the gastrointestinal border [].
Additionally, cyanotoxins may directly affect the thyroid gland. It was recently reported that microcystin-LR is able to affect the HPT, the hypothalamic–pituitary–gonadal, and the hypothalamic–pituitary–adrenal endocrine axes in rats. In regard to the HPT axis, microcystin-LR increased the concentration of TSH and decreased TRH and plasma levels of free T3 and T4 []. All three axes under study were influenced at the gene transcription level of the hormones and the nuclear hormone receptors. These results are in line with the effect of chronic oral administration of low doses of microcystin-LR, which leads to activation of p38/MAPK and MEK/ERK cell signaling that up-regulates type 3 deiodinase expression in mice [].
In conclusion, drinking water and foods contaminated with cyanotoxins may indirectly influence plasma levels of free T3 and T4 via proinflammatory mucosal reaction and dysbiosis, or by a direct effect on the HPT axis and the thyroid in particular. Some of these stimuli may challenge the thyroid function and can be linked to TH. Effects of other toxins, different from the nutritional factors and cyanotoxins discussed above, on the thyroid gland and TH are not in the scope of this review.
2.4. Diets Favoring Inflammation and Gut Dysbiosis and Their Role in Thyroiditis of Hashimoto
Diet and microbiota are among the main factors in gut inflammation and proper intestinal function [,,]. Foods rich in antioxidants help the body control oxidative stress and exert anti-inflammatory effects. These foods are considered healthy and good for maintaining an optimal body mass index. On the other hand, some diets are rich in proinflammatory foods and thus have a substantial impact on the inflammation in the human body. Research shows that certain foods can affect C-reactive protein (CRP) production, which is a serum marker of inflammation []. The consumption of some foods causes the release of inflammatory messengers that raise the risk of chronic inflammation, cancer, diabetes, metabolic syndrome, autoimmune diseases, and other chronic conditions (Table 3).
Table 3.
Diets, inflammation, and microbiota.
Accumulated data for different diets and their effects on inflammation and microbiota are summarized in Table 3.
The disruption of gut microbiota, also known as gut dysbiosis, is influenced by the individual genetic profile, diet, antibiotics, and inflammation. It is linked to the pathogenesis of some inflammatory diseases, such as obesity and inflammatory bowel disease []. Intestinal dysbiosis and increased intestinal permeability seem to favor the progress of TH as well, while no alteration in systemic cytokines could be detected within the same group of study []. Nevertheless, dietary modulation of the microbial gut balance affects the inflammatory environment, most probably due to the microbiota metabolites. Microbiota-derived metabolites, short-chain fatty acids, and Gram-negative bacterial lipopolysaccharides (LPS) exert anti-inflammatory or proinflammatory effects by acting on macrophages, depending on their M1 and M2 phenotypes []. Butyrate, a commensal microbial fermentation product, has been shown to favor the polarization and function of M2 macrophages through interleukin 4 (IL-4)-mediated STAT6 transcription, which could attenuate intestinal inflammation in mice [].
A simulation model of interaction between thyroid follicular cells, Th1, Th17, Tregs, and gut microbiota in TH pathogenesis was recently proposed by Salazar-Viedma et al. []. Their model showed that increased proliferation and differentiation of Th1 and Th17 lymphocytes indirectly trigger inflammation and apoptosis of healthy thyrocytes. Furthermore, imbalanced gut microbiota composition results in a reduction of Treg cells and stimulation of Th17 lymphocytes, thus contributing to inflammation processes and apoptosis of healthy thyrocytes [].
The impact of foods, the diversity of microbiota metabolites, and their interference with the immune cells’ balance in patients with TH are scarce and require further clarification to understand the mechanisms behind the development of this disease and find nutritional strategies for its alleviation.
2.5. Proinflammatory Nutrients Favoring Clinical Manifestation of Endocrine and Metabolic Disease
Some foods can be described as proinflammatory or anti-inflammatory depending on their content—proinflammatory or anti-inflammatory nutrients. A diet rich in too many proinflammatory nutrients may increase the risk of chronic inflammation and could accelerate the inflammatory disease process. Therefore, it is essential to not only recognize foods which can elicit inflammation, but also the inflammatory nutrients that are present in the food (Table 4).
Table 4.
Inflammatory nutrients.
Some foods associated with weight gain and an increased risk for chronic diseases such as heart disease and type 2 diabetes are also linked to elevated inflammatory reactions. Again, it is because some of the food ingredients or nutrients may have independent effects on inflammation.
3. The Role of Thyroid–Gut Axis and the Influence of Gut Microbiota on TH
There is mounting evidence for the existence of a robust thyroid–gut axis. It is reflected by a significant influence of the intrinsic bacterial microflora in the gut on the immune system reactivity and the thyroid function []. Furthermore, the concomitance of thyroid- and gut-related disorders is common, such as TH/Graves’ disease and celiac disease/non-celiac wheat sensitivity. Thyroid diseases are frequently associated with dysbiosis.
Dysbiosis may significantly impair the immune system and compromise inflammatory control, causing autoimmune illnesses such as autoimmune thyroid diseases [,]. Moreover, microbiota influences the intake of thyroid-related minerals such as iodine, selenium, zinc, and iron. They all have a role in thyroid function, and there is a definite correlation between thyroid disease and changed amounts of these minerals in the body [].
Aside from that, it appears that Lactobacillaceae and Bifidobacterium spp. have a negative association with dietary iron and a favorable correlation with selenium and zinc. Since these bacteria are reduced in TH and Grave’s disease, it has been assumed that gut composition and mineral regulation may play a role in both disorders [].
Furthermore, Lactobacillaceae and Bifidobacteriaceae are frequently decreased in hypo- and hyperthyroidism. Supplementation with Lactobacillus reuteri improved thyroid function in rats by increasing free T4, thyroid gland mass, and physiological indices, such as more dynamic behavior. This result might be caused by interleukin-10, which is known to enhance the T-regulatory cells [].
Symbiotic supplementation is a mixture of pro- and pre-biotics that has been shown in a recent study to benefit individuals with hypothyroidism by considerably lowering TSH, levothyroxine dosage, and exhaustion, while raising fT3. However, no effect on anti-TPO or blood pressure was demonstrated [].
It has not been determined whether bacterial infections can cause autoimmune thyroid diseases or influence therapy efficacy and prognosis [].
Considering the numerous possible effects of microbiota and micronutrients on thyroid functions and medicines, innovative treatment methods for the management of thyroid illnesses might be developed and tailored to individuals based on their gut flora composition. Future detailed research in humans is of particular importance to delineate the influence of gut microbiota on thyroid function and disease.
Gut–thyroid interaction, and its relation with dysbiosis, changes in the immune response, increased intestinal permeability, and inflammation are presented on Figure 1.
Figure 1.
Gut–thyroid interaction in health and disease (autoimmune thyroid pathology and cancer). Thyroid diseases are frequently associated with dysbiosis. On the one hand, dysbiosis changes the immune response by encouraging inflammation and decreasing immunological tolerance, disrupting the intestinal membrane and increased intestinal permeability (a.k.a., “leaky gut”), resulting in increased antigen exposure and local inflammation. On the other hand, dysbiosis can directly affect thyroid hormone levels due to bacterial deiodinase activity and TSH inhibition []. The gut microbiota also regulates the absorption of thyroid-related nutrients such as iodine, selenium, zinc, and iron. All of them are required for thyroid function, and there is a definite correlation between thyroid dysfunction and changes in these minerals’ levels. Probiotics have been demonstrated to be effective in thyroid problems and can have a good effect. The healthy or diseased thyroid gland can also influence microbiota via many mechanisms, including melatonin. Legend: green arrows (wide and thin) denote a predominantly positive impact, while pink arrows (wide and narrow) indicate a primarily negative effect.
4. Endocrine and Immune Regulators Involved in Adaptation: Vitamin D and Melatonin
4.1. Essential Effects of Vitamin D and Melatonin on Body Physiology and Cell Function
Both vitamin D and melatonin play an essential role in body physiology by controlling a variety of endocrine and immune responses. Their endogenous rhythmic production is related to the environmental cycling of light and darkness and is essentially important for ubiquitous cell physiology. Since proper circadian activity of immune and endocrine axes is a remarkable sign of overall health, vitamin D and melatonin are both promising candidates to be involved in the nutritional management of TH [].
Data from clinical studies reveal increased prevalence of autoimmune multiple sclerosis (MS) in countries at high latitudes, where the natural lighting regimen favors vitamin D deficiency and high melatonin levels. Findings from a randomized, double-blind study on interferon beta (IFN-β)-treated patients with MS showed that melatonin secretion is negatively correlated with alterations in serum 25-hydroxyvitamin D3 (25-OH-D3), which may suggest potential interactions between both hormones with beneficial neuro-immunomodulating effects under deteriorated immune responses [].
Vitamin D is synthesized in the skin when exposed to ultraviolet radiation from the sun and can be present in certain foods, similar to melatonin and its derivatives []. Both hormones have been shown to be involved in the modulation of processes such as proliferation and differentiation of normal and cancer cells, cardiovascular function, as well as immunomodulation []. Melatonin, known as the “message of darkness” to body physiology, is a hormone produced with a circadian pattern from the pineal gland during the dark period of the day–night cycle. Circadian rhythmicity of hormonal secretion and immune cells’ reactivity is a remarkable feature of healthy physiology which ensures adaptation to environmental stimuli by maintaining sensitive hormone–receptor interactions and regulatory negative feedback loops. The rhythmic pattern of endogenous melatonin peripheral concentration is affected under several disease conditions, particularly in psychiatric and autoimmune diseases, but also in cancer [].
Although the synthesis of vitamin D and melatonin is in opposite phases of the day–night cycle, both hormones have been shown to be involved in modulating the activity of the immune system. Authors have suggested that while light affects melatonin synthesis, vitamin D deficiency may be related to adverse changes in circulating melatonin secretion []. A mechanism has been proposed by which vitamin D deficiency can cause an inflammatory response in the brain, and especially in the pineal gland, through decreased calcium absorption and gut stasis, permeability deterioration, and a corresponding increase in systemic endotoxins transferred by the intestinal microbiota.
Evidence has been provided that in addition to the protective role of vitamin D with regard to immune system alertness under different infection diseases, it may have an impact in cognitive, behavioral, and mood disorders by playing a vital role in serotonin and melatonin regulation, which are linked to mental health, especially mood regulation and sleep [].
4.2. Deficits of Vitamin D and Melatonin Linked to Autoimmune Predisposition
Vitamin D deficiency has been especially demonstrated in TH patients. This may be due to the insufficiency of its natural effects on multiple immune cell-type differentiation and maturation, antigen presentation, as well as regulation of the production of cytokines and chemokines. In monocytes/macrophages, vitamin D has been shown to inhibit the expression of Toll-like receptor (TLR) 2/4 and the production of inflammatory cytokines such as IL-1, IL-6, and TNF-α. Therefore, vitamin D deficiency plays a crucial pathogenic role in autoimmune diseases [].
Deficiency in vitamin D synthesis has been linked to autoimmune disorders associated with significant sex differences due to genetic, epigenetic, hormonal, and environmental factors []. It is well-established that estrogens exert dose-dependent effects on the immune response by shifting T-cell subsets to a Th1 or a Th2 profile []. The synthesis of estrogens and their varying concentrations during different phases related to reproductive function in women have long been associated with increased immune protection in females. In addition, estrogens have been shown to improve the function of vitamin D by promoting the expression of vitamin D receptors. These differences related to gender genetics and the associated hormonal background are an interesting direction for the development of individualized therapeutic approaches to autoimmune diseases [].
5. Nutritional Treatment Strategies of Thyroiditis of Hashimoto
5.1. Anti-Inflammatory Nutrients
An exponentially growing number of papers are focused on anti-inflammatory foods and their impact on health. Anti-inflammatory nutrients are those nutrients that can alter the expression of the inflammatory genes. Therefore, they are employed in different nutritional regimens to reduce inflammation and re-establish hormonal balance [].
Furthermore, implementing these nutrients in the diet can help to maintain good nutrition while silencing inflammation. Therefore, they are considered as a novel molecular cutting-edge approach. The main anti-inflammatory nutrients are presented in Table 5.
Table 5.
Anti-inflammatory nutrients.
5.2. Adaptive Responses Involved in the Control of Immune Reactions
Melatonin has been investigated in the therapy of several autoimmune diseases, including systemic lupus erythematosus, MS, type 1 diabetes mellitus, rheumatoid arthritis, and inflammatory bowel disease, with controversial results. However, its impact in autoimmune thyroid diseases (AITD), including Graves’ disease (GD) and TH, has been examined in rare cases. For example, a recent study investigated the possible associations of single-nucleotide polymorphisms (SNPs) of melatonin receptor type 1A (MTNR1A) and 1B (MTNR1B) with AITD in an ethnic Chinese population. The authors found only genetic variants of MTNR1A but not MTNR1B to be associated with susceptibility to GD [].
Melatonin was shown to regulate mucosal immunity and protect against gut inflammation, at least in ulcerative colitis, a chronic inflammatory disease of the colon. Nevertheless, its role in response to LPS remains controversial []. The rise in LPS levels expressed by the gut microbiota increases the blood LPS through gut inflammation. LPS is recognized by LPS-binding protein (LBP) in the serum, which brings the LPS to the surface of various cells such as macrophages and endothelial cells to form a complex with CD14, a receptor molecule for LPS []. Providing a comprehensive review of environmental and existential factors with an impact on MS, the authors use a mechanistic approach to propose a new pathway leading to neuroinflammation and MS by including different factors such as latitude, sunlight, vitamin D, melanopsin, intestinal calcium, pineal gland, gut stasis, gut endotoxins (LPS), and CD14/TLR4 []. They proposed a leading role of LPS produced by gut microbiota for the etiopathogenesis of MS by generating neuroinflammation and deterioration of melatonin synthesis []. If such a pathway can be applicable to TH and other autoimmune disorders remains to be explored.
5.3. Beneficial Effects of Vitamin D and Melatonin as Antioxidants
Melatonin has several biological functions, including control of circadian and seasonal rhythms, ROS scavenging, influence on puberty, etc. However, the relationship between melatonin and the HPT axis remains controversial []. For example, one animal study showed that TSH was higher in the melatonin-treated group than the control group. At the same time, there was no significant difference in peripheral thyroid function. In contrast, another study demonstrated that melatonin could inhibit TSH secretion and directly inhibit the secretion of T4 [].
In regard to thyroid gland function, research has focused mostly on a specific feature of melatonin—its potent antioxidant activity. Antioxidants remove potentially damaging reactive oxygen species (ROS) generated in the cells during their life. ROS are essential and trigger the so-called oxidative reactions, which when in excess can cause damage to macromolecules, thus violating their proper functioning []. In the thyroid gland, ROS are necessary for completing the synthesis of thyroid hormones. Some research showed that parafollicular cells of the thyroid gland which secrete calcitonin are capable of serotonin and melatonin production, and that this is influenced locally by TSH. It seems that melatonin and TSH balance themselves out, but there is no convincing evidence showing this. It is generally accepted that alterations in the circadian pattern of melatonin secretion are indicative of health problems and distress. Melatonin may block thyroid cell proliferation and thyroid hormone synthesis [], and its use as a dietary supplement has to be controlled in regard to thyroid function to prevent compromised disease management.
Melatonin is widely accessible over the counter as a sleep aid. According to the National Institutes of Health, short-term use of melatonin supplements appears safe. Still, very little research exists on the long-term effects. A study from 2001 looked at the impact of melatonin on females with hypothyroidism, 36 of whom were perimenopausal, and 18 were postmenopausal []. The study revealed that the group taking melatonin at bed time showed significantly higher thyroid hormone levels than the placebo group after 3–6 months, and the participants experienced improvement of mood and overall alertness. The authors suggested that low melatonin levels due to aging may be connected with low levels of thyroid hormones, explaining why taking a melatonin supplement also improved TSH levels []. Unfortunately, large-scale trials to confirm that melatonin is safe and effective for people with hypothyroidism are still lacking.
5.4. Diets Aimed at Liver Detoxication and Cleansing
The nutritional management of TH includes liver detoxification and heavy metal cleansing. Promising studies report the detoxification effect of diets, often combined with an exercise plan, that additionally lead to weight loss and improved health []. Detoxification or detoxication is the physiological removal of toxic substances from the human body, which is carried out mainly by the liver, kidneys, intestines, lungs, lymphatic system, and the skin. However, when organs and systems are compromised, toxins and other impurities are not properly excreted, and the body is adversely affected by inflammation and the autoimmune response. The accumulation of heavy metals in the human body leads to severe injury to various organs, specifically the nervous, respiratory, endocrine, gastrointestinal, and reproductive systems [,]. Many foods were found to protect the human body via anti-inflammatory, antioxidative, anti-cancer, antibacterial, and other properties due to their detoxicating and cleansing effects on the liver, kidney, blood, gut, and other organs and tissues (Table 6).
Table 6.
Foods for cleansing and detoxication.
5.5. Ecological Dietary Regimen for TH
Malnutrition risk in TH patients has not been adequately explored, and no precise conclusions may be drawn []. Currently, there is no convincing evidence for an effective clinical indication of dietary supplementation with vitamin D and melatonin as a complementary treatment against TH symptomatology. It is important to note that melatonin modulates the immune system by suppressing proinflammatory molecules in a dose-dependent fashion due to its physiological circadian pattern. The differences in its function can come from the dose when taken as a medication, 10 or 100 times higher than the levels produced generally in the healthy body []. The timing of assessment and dose–response dynamics may be essential aspects to consider when investigating the effects of vitamin D on mood and sleep due to potential vitamin D-induced moderations in serotonin and melatonin synthesis.
6. Perspectives for Nutritional Management of Thyroiditis of Hashimoto
Diet therapy for Hashimoto’s thyroiditis is focused on optimal nutrition and immune system modulation through an anti-inflammatory diet []. Since nutritional deficits are common in TH patients, according to observational and controlled investigations, nutritional management is considered essential for management of TH patients. There is evidence in the literature for selenium, potassium, iodine, copper, magnesium, zinc, iron, and vitamin A, C, D, and B deficiency in TH patients []. Additionally, it has been suggested that adequate protein consumption, dietary fiber, and unsaturated fatty acids, particularly those of the omega-3 family, play a beneficial role [].
Melatonin therapy in autoimmune diseases has been studied in many animal models and in a few human clinical trials []. For all the conditions except rheumatoid arthritis, melatonin has been shown to have the potential to reduce the severity of symptoms. These findings indicate that melatonin treatment could be an important strategy for Hashimoto’s condition. However, convincing research on this topic is lacking, especially in light of melatonin’s complex role as an endocrine and immune modulator, but also as an active molecule at the cellular level. The most important question concerns the proper timing and dosing of melatonin, bearing in mind its circadian pattern of endogenous release and opposite phase to vitamin D and serotonin. It may be that melatonin-controlled dosing may be important to help for an overall improvement of adaptive responses, including psycho-emotional, neuroimmune, and endocrine circuits []. Certainly, more research is needed, in particular to better understand the delicate balance between melatonin and thyroid gland function.
7. Conclusions
For most TH patients, the hormone-replacement therapy with levothyroxine is indispensable. Nevertheless, an appropriate dietary regimen and ecological lifestyle can complement the standard treatment and favor remission of TH by improving the function of the thyroid gland, as well as by regulating the levels of TSH, T3, T4, Ab-TRO, and Ab-Tg. Other less significant parameters may be a repercussion of healthier body reactions and improvement of life quality, such as better sleep and alertness. Compliance with nutritional guidelines with a focus on the prevailing anti-inflammatory diet and controlled vitamin D dosing may help individual TH patients to reduce the need for medicines, slow down the course of the disease, and avoid relapses.
Author Contributions
Conceptualization, Z.M., A.S., T.V., R.K., and H.G.; methodology, T.V., R.K., and H.G.; writing—original draft preparation, Y.D., T.V., R.K., and H.G.; writing—review and editing, Y.D., G.N., and H.G.; supervision, R.K. and H.G.; project administration, T.V., R.K., and H.G.; funding acquisition, R.K. and H.G. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by H2020 INFRADEV-3-2019, Grant No. 871096 “EATRIS-Plus”, and by Grant KP-06-OPR03/18 from the Scientific Research Fund of the Ministry of Education and Science of Bulgaria.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
No new data were created or analyzed in this study. Data sharing is not applicable to this article.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Hu, S.; Rayman, M.P. Multiple Nutritional Factors and the Risk of Hashimoto’s Thyroiditis. Thyroid 2017, 27, 597–610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Okayasu, I.; Hara, Y.; Nakamura, K.; Rose, N.R. Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am. J. Clin. Pathol. 1994, 101, 698–702. [Google Scholar] [CrossRef] [PubMed]
- Krysiak, R.; Szkróbka, W.; Okopień, B. The Effect of Gluten-Free Diet on Thyroid Autoimmunity in Drug-Naïve Women with Hashimoto’s Thyroiditis: A Pilot Study. Exp. Clin. Endocrinol. Diabetes 2019, 127, 417–422. [Google Scholar] [CrossRef] [Green Version]
- Ihnatowicz, P.; Drywień, M.; Wątor, P.; Wojsiat, J. The importance of nutritional factors and dietary management of Hashimoto’s thyroiditis. Ann. Agric. Environ. Med. 2020, 27, 184–193. [Google Scholar] [CrossRef] [PubMed]
- Caturegli, P.; De Remigis, A.; Rose, N.R. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun. Rev. 2014, 13, 391–397. [Google Scholar] [CrossRef] [PubMed]
- Subekti, I.; Pramono, L.A. Current diagnosis and management of Graves’ disease. Acta Med. Indones. 2018, 50, 177–182. [Google Scholar] [PubMed]
- Wiersinga, W.M. Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease. Endocrinol. Metab. 2016, 31, 213–222. [Google Scholar] [CrossRef]
- Weetman, A.P. An update on the pathogenesis of Hashimoto’s thyroiditis. J. Endocrinol. Investig. 2021, 44, 883–890. [Google Scholar] [CrossRef]
- Rayman, M.P. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc. Nutr. Soc. 2019, 78, 34–44. [Google Scholar] [CrossRef] [Green Version]
- Benvenga, S.; Ferrari, S.M.; Elia, G.; Ragusa, F.; Patrizio, A.; Paparo, S.R.; Camastra, S.; Bonofiglio, D.; Antonelli, A.; Fallahi, P. Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies. Nutrients 2020, 12, 1337. [Google Scholar] [CrossRef]
- Ceballos, D.; Hernández-Camba, A.; Ramos, L. Diet and microbiome in the beginning of the sequence of gut inflammation. World J. Clin. Cases 2021, 9, 11122–11147. [Google Scholar] [CrossRef] [PubMed]
- Kochman, J.; Jakubczyk, K.; Bargiel, P.; Janda-Milczarek, K. The Influence of Oxidative Stress on Thyroid Diseases. Antioxidants 2021, 10, 1442. [Google Scholar] [CrossRef] [PubMed]
- Cayres, L.C.F.; de Salis, L.V.V.; Rodrigues, G.S.P.; Lengert, A.V.H.; Biondi, A.P.C.; Sargentini, L.D.B.; Brisotti, J.L.; Gomes, E.; de Oliveira, G.L.V. Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis. Front. Immunol. 2021, 12, 579140. [Google Scholar] [CrossRef] [PubMed]
- Fröhlich, E.; Wahl, R. Microbiota and Thyroid Interaction in Health and Disease. Trends Endocrinol. Metab. 2019, 30, 479–490. [Google Scholar] [CrossRef] [Green Version]
- Chichova, M.; Tasinov, O.; Shkodrova, M.; Mishonova, M.; Sazdova, I.; Ilieva, B.; Doncheva-Stoimenova, D.; Kiselova-Kaneva, Y.; Raikova, N.; Uzunov, B.; et al. New Data on Cylindrospermopsin Toxicity. Toxins 2021, 13, 41. [Google Scholar] [CrossRef]
- Chen, J.; Bian, R.; Li, J.; Qiu, L.; Lu, B.; Ouyang, X. Chronic exposure to microcystin-LR reduces thyroid hormone levels by activating p38/MAPK and MEK/ERK signal pathway. Ecotoxicol Environ. Saf. 2019, 173, 142–148. [Google Scholar] [CrossRef]
- Chen, L.; Shi, T.; Wang, Y.T.; He, J.; Zhao, X.; Wang, Y.K.; Giesy, J.P.; Chen, F.; Chen, Y.; Tuo, X.; et al. Effects of acute exposure to microcystins on hypothalamic-pituitary-adrenal (HPA), -gonad (HPG) and -thyroid (HPT) axes of female rats. Sci. Total Environ. 2021, 778, 145196. [Google Scholar] [CrossRef]
- Błażewicz, A.; Wiśniewska, P.; Skórzyńska-Dziduszko, K. Selected Essential and Toxic Chemical Elements in Hypothyroidism-A Literature Review (2001–2021). Int. J. Mol. Sci. 2021, 22, 10147. [Google Scholar] [CrossRef]
- Baltaci, A.K.; Mogulkoc, R.; Baltaci, S.B. Review: The role of zinc in the endocrine system. Pak. J. Pharm. Sci. 2019, 32, 231–239. [Google Scholar]
- Kawicka, A.; Regulska-Ilow, B. Metabolic disorders and nutritional status in autoimmune thyroid diseases. Postepy Hig. Med. Dosw. 2015, 69, 80–90. [Google Scholar] [CrossRef]
- Kim, D. The Role of Vitamin D in Thyroid Diseases. Int. J. Mol. Sci. 2017, 18, 1949. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pałkowska-Goździk, E.; Lachowicz, K.; Rosołowska-Huszcz, D. Effects of Dietary Protein on Thyroid Axis Activity. Nutrients 2017, 10, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Azami, M.; Parizad, N.; Sayehmiri, K. Prevalence of hypothyroidism, hypoparathyroidism and thefrequency of regular chelation therapy in patients with thalassemia major in Iran: A systematic review and meta-analysis study. Iran. J. Ped. Hematol. Oncol. 2016, 6, 260–275. [Google Scholar]
- Cayir, A.; Doneray, H.; Kurt, N.; Orbak, Z.; Kaya, A.; Turan, M.I.; Yildirim, A. Thyroid Functions and Trace Elements in Pediatric Patients with Exogenous Obesity. Biol. Trace Elem. Res. 2014, 157, 95–100. [Google Scholar] [CrossRef]
- Memon, N.S.; Kazi, T.G.; Afridi, H.I.; Baig, J.A.; Sahito, O.M.; Baloch, S.; Waris, M. Correlation of Manganese with Thyroid Function in Females Having Hypo- and Hyperthyroid Disorders. Biol. Trace Elem. Res. 2015, 167, 165–171. [Google Scholar] [CrossRef]
- Stojsavljevic, A.; Rovcanin, B.; Jagodic, J.; Radojkovic, D.D.; Paunovic, I.; Gavrovic-Jankulovic, M.; Manojlovic, D. Significance of Arsenic and Lead in Hashimoto’s Thyroiditis Demonstrated on Thyroid Tissue, Blood, and Urine Samples. Environ. Res. 2020, 186, 109538. [Google Scholar] [CrossRef]
- Jain, R.B.; Choi, Y.S. Interacting effects of selected trace and toxic metals on thyroid function. Int. J. Environ. Health Res. 2016, 26, 75–91. [Google Scholar] [CrossRef]
- Benvenga, S.; Marini, H.R.; Micali, A.; Freni, J.; Pallio, G.; Irrera, N.; Squadrito, F.; Altavilla, D.; Antonelli, A.; Ferrari, S.M.; et al. Protective Effects of Myo-Inositol and Selenium on Cadmium-Induced Thyroid Toxicity in Mice. Nutrients 2020, 12, 1222. [Google Scholar] [CrossRef]
- Talebi, S.; Ghaedi, E.; Sadeghi, E.; Mohammadi, H.; Hadi, A.; Clark, C.C.T.; Askari, G. Trace Element Status and Hypothyroidism: A Systematic Review and Meta-Analysis. Biol. Trace Elem. Res. 2020, 197, 1–14. [Google Scholar] [CrossRef]
- Igbokwe, I.O.; Igwenagu, E.; Igbokwe, N.A. Aluminium toxicosis: A review of toxic actions and effects. Interdiscip. Toxicol. 2019, 12, 45–70. [Google Scholar] [CrossRef] [Green Version]
- Genchi, G.; Carocci, A.; Lauria, G.; Sinicropi, M.S.; Catalano, A. Nickel: Human Health and Environmental Toxicology. Int. J. Environ. Res. Public Health 2020, 17, 679. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dopp, E.; Rettenmeier, A.W. Tin, Toxicity. In Encyclopedia of Metalloproteins; Kretsinger, R.H., Uversky, V.N., Permyakov, E.A., Eds.; Springer: New York, NY, USA, 2013. [Google Scholar] [CrossRef]
- Chitambar, C.R. Medical Applications and Toxicities of Gallium Compounds. Int. J. Environ. Res. Public Health 2010, 7, 2337–2361. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bitto, A.; Polito, F.; Atteritano, M.; Altavilla, D.; Mazzaferro, S.; Marini, H.; Adamo, E.B.; D’Anna, R.; Granese, R.; Corrado, F.; et al. Genistein aglycone does not affect thyroid function: Results from a three-year, randomized, double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 2010, 95, 3067–3072. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Marini, H.; Polito, F.; Adamo, E.B.; Bitto, A.; Squadrito, F.; Benvenga, S. Update on genistein and thyroid: An overall message of safety. Front. Endocrinol. 2012, 3, 94. [Google Scholar] [CrossRef] [Green Version]
- Meriluoto, J.; Spoof, L.; Codd, G.A. (Eds.) Handbook of Cyanobacterial Monitoring and Cyanotoxin Analysis; John Wiley & Sons: Chichester, UK, 2017. [Google Scholar]
- Mills, M.C.; Evans, M.V.; Lee, S.; Knobloch, T.; Weghorst, C.; Lee, J. Acute cyanotoxin poisoning reveals a marginal effect on mouse gut microbiome composition but indicates metabolic shifts related to liver and gut inflammation. Ecotoxicol. Environ. Saf. 2021, 215, 112126. [Google Scholar] [CrossRef]
- Kubickova, B.; Babica, P.; Hilscherová, K.; Šindlerová, L. Effects of cyanobacterial toxins on the human gastrointestinal tract and the mucosal innate immune system. Environ. Sci. Eur. 2019, 31, 31. [Google Scholar] [CrossRef] [Green Version]
- Arman, T.; Clarke, J.D. Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans. Toxins 2021, 13, 537. [Google Scholar] [CrossRef]
- Zhang, Q.; Wang, L.; Chen, G.; Wang, M.; Hu, T. Cylindrospermopsin impairs vascular smooth muscle cells by P53-mediated apoptosis due to ROS overproduction. Toxicol. Lett. 2021, 353, 83–92. [Google Scholar] [CrossRef]
- Sazdova, I.; Keremidarska-Markova, M.; Chichova, M.; Uzunov, B.; Georgiev, G.; Mladenov, M.; Schubert, R.; Stoyneva-Gärtner, M.; Gagov, H.S. Review of Cyanotoxicity Studies Based on Cell Cultures. J. Toxicol. 2022, 2022, 5647178. [Google Scholar] [CrossRef]
- Passali, M.; Josefsen, K.; Frederiksen, J.L.; Antvorskov, J.C. Current Evidence on the Efficacy of Gluten-Free Diets in Multiple Sclerosis, Psoriasis, Type 1 Diabetes and Autoimmune Thyroid Diseases. Nutrients 2020, 12, 2316. [Google Scholar] [CrossRef]
- Sproston, N.R.; Ashworth, J.J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol. 2018, 9, 754. [Google Scholar] [CrossRef] [PubMed]
- Hwang, C.; Ross, V.; Mahadevan, U. Popular exclusionary diets for inflammatory bowel disease: The search for a dietary culprit. Inflamm. Bowel Dis. 2014, 20, 732–741. [Google Scholar] [CrossRef] [PubMed]
- Walters, S.S.; Quiros, A.; Rolston, M.; Grishina, I.; Li, J.; Fenton, A.; DeSantis, T.Z.; Thai, A.; Andersen, G.L.; Papathakis, P.; et al. Analysis of Gut Microbiome and Diet Modification in Patients with Crohn’s Disease. SOJ Microbiol. Infect. Dis. 2014, 2, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olendzki, B.C.; Silverstein, T.D.; Persuitte, G.M.; Ma, Y.; Baldwin, K.R.; Cave, D. An anti-inflammatory diet as treatment for inflammatory bowel disease: A case series report. Nutr. J. 2014, 13, 5. [Google Scholar] [CrossRef] [Green Version]
- Konijeti, G.G.; Kim, N.; Lewis, J.D.; Groven, S.; Chandrasekaran, A.; Grandhe, S.; Diamant, C.; Singh, E.; Oliveira, G.; Wang, X.; et al. Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2017, 23, 2054–2060. [Google Scholar] [CrossRef]
- Maes, M.; Leunis, J.C. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: Effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuroendocrinol. Lett. 2008, 29, 902–910. [Google Scholar]
- Sen, T.; Cawthon, C.R.; Ihde, B.T.; Hajnal, A.; DiLorenzo, P.M.; de La Serre, C.B.; Czaja, K. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol. Behav. 2017, 173, 305–317. [Google Scholar] [CrossRef] [Green Version]
- Inglis, J.E.; Lin, P.J.; Kerns, S.L.; Kleckner, I.R.; Kleckner, A.S.; Castillo, D.A.; Mustian, K.M.; Peppone, L.J. Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. Nutr. Cancer 2019, 71, 21–40. [Google Scholar] [CrossRef]
- Lankinen, M.; Uusitupa, M.; Schwab, U. Nordic Diet and Inflammation-A Review of Observational and Intervention Studies. Nutrients 2019, 11, 1369. [Google Scholar] [CrossRef] [Green Version]
- Kharrazian, D.; Herbert, M.; Vojdani, A. Immunological Reactivity Using Monoclonal and Polyclonal Antibodies of Autoimmune Thyroid Target Sites with Dietary Proteins. J. Thyroid Res. 2017, 2017, 4354723. [Google Scholar] [CrossRef]
- Hargreaves, C.E.; Grasso, M.; Hampe, C.S.; Stenkova, A.; Atkinson, S.; Joshua, G.W.; Wren, B.W.; Buckle, A.M.; Dunn-Walters, D.; Banga, J.P. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves’ disease. J. Immunol. 2013, 190, 5373–5381. [Google Scholar] [CrossRef] [Green Version]
- Diether, N.E.; Willing, B.P. Microbial Fermentation of Dietary Protein: An Important Factor in Diet—Microbe—Host Interaction. Microorganisms 2019, 7, 19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Haß, U.; Herpich, C.; Norman, K. Anti-Inflammatory Diets and Fatigue. Nutrients 2019, 11, 2315. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Christ, A.; Lauterbach, M.; Latz, E. Western Diet and the Immune System: An Inflammatory Connection. Immunity 2019, 51, 794–811. [Google Scholar] [CrossRef] [PubMed]
- Jung, S.; Kim, W.-L.; Park, B.-H.; Lee, S.-O.; Chae, S.-W. Effect of toxic trace element detoxification, body fat reduction following four-week intake of the Wellnessup diet: A three-arm, randomized clinical trial. Nutr. Metab. 2020, 17, 47. [Google Scholar] [CrossRef]
- Altobelli, E.; Del Negro, V.; Angeletti, P.M.; Latella, G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients 2017, 9, 940. [Google Scholar] [CrossRef]
- Rakel, D. The Elimination Diet. In Integrative Medicine, 4th ed.; Elsevier: Amsterdam, The Netherlands, 2018; Chapter 86. [Google Scholar]
- Wang, K.; Wei, H.; Zhang, W.; Li, Z.; Ding, L.; Yu, T.; Tan, L.; Liu, Y.; Liu, T.; Wang, H.; et al. Severely low serum magnesium is associated with increased risks of positive anti- thyroglobulin antibody and hypothyroidism: A cross-sectional study. Sci. Rep. 2018, 8, 9904. [Google Scholar] [CrossRef] [Green Version]
- Forbes, J.D.; Chen, C.Y.; Knox, N.C.; Marrie, R.A.; El-Gabalawy, H.; de Kievit, T.; Alfa, M.; Bernstein, C.N.; Van Domselaar, G. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome 2018, 6, 221. [Google Scholar] [CrossRef]
- Ji, J.; Shu, D.; Zheng, M.; Wang, J.; Luo, C.; Wang, Y.; Guo, F.; Zou, X.; Lv, X.; Li, Y.; et al. Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci. Rep. 2016, 6, 24838. [Google Scholar] [CrossRef]
- Salazar-Viedma, M.; Vergaño-Salazar, J.G.; Pastenes, L.; D’Afonseca, V. Simulation Model for Hashimoto Autoimmune Thyroiditis Disease. Endocrinology 2021, 162, bqab190. [Google Scholar] [CrossRef]
- Bruun, J.M.; Maersk, M.; Belza, A.; Astrup, A.; Richelsen, B. Consumption of sucrose-sweetened soft drinks increases plasma levels of uric acid in overweight and obese subjects: A 6-month randomised controlled trial. Eur. J. Clin. Nutr. 2015, 69, 949–953. [Google Scholar] [CrossRef] [PubMed]
- Lopez-Garcia, E.; Schulze, M.B.; Meigs, J.B.; Manson, J.E.; Rifai, N.; Stampfer, M.J.; Willett, W.C.; Hu, F.B. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 2005, 135, 562–566. [Google Scholar] [CrossRef] [PubMed]
- Dixon, L.J.; Kabi, A.; Nickerson, K.P.; McDonald, C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm. Bowel Dis. 2015, 21, 912–922. [Google Scholar] [CrossRef] [PubMed]
- Hammerling, U.; Bergman Laurila, J.; Grafström, R.; Ilbäck, N.G. Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association. Crit. Rev. Food Sci. Nutr. 2016, 56, 614–634. [Google Scholar] [CrossRef]
- Oliveira, A.; Rodríguez-Artalejo, F.; Lopes, C. Alcohol intake and systemic markers of inflammation—Shape of the association according to sex and body mass index. Alcohol Alcohol. 2010, 45, 119–125. [Google Scholar] [CrossRef]
- Papier, K.; Hartman, L.; Tong, T.; Key, T.J.; Knuppel, A. Higher Meat Intake Is Associated with Higher Inflammatory Markers, Mostly Due to Adiposity: Results from UK Biobank. J. Nutr. 2022, 152, 183–189. [Google Scholar] [CrossRef]
- Chai, W.; Morimoto, Y.; Cooney, R.V.; Franke, A.A.; Shvetsov, Y.B.; Le Marchand, L.; Haiman, C.A.; Kolonel, L.N.; Goodman, M.T.; Maskarinec, G. Dietary Red and Processed Meat Intake and Markers of Adiposity and Inflammation: The Multiethnic Cohort Study. J. Am. Coll. Nutr. 2017, 36, 378–385. [Google Scholar] [CrossRef]
- Knezevic, J.; Starchl, C.; Tmava Berisha, A.; Amrein, K. Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? Nutrients 2020, 12, 1769. [Google Scholar] [CrossRef]
- Virili, C.; Fallahi, P.; Antonelli, A.; Benvenga, S.; Centanni, M. Gut microbiota and Hashimoto’s thyroiditis. Rev. Endocr. Metab. Disord. 2018, 19, 293–300. [Google Scholar] [CrossRef]
- Docimo, G.; Cangiano, A.; Romano, R.M.; Pignatelli, M.F.; Offi, C.; Paglionico, V.A.; Galdiero, M.; Donnarumma, G.; Nigro, V.; Esposito, D.; et al. The Human Microbiota in Endocrinology: Implications for Pathophysiology, Treatment, and Prognosis in Thyroid Diseases. Front. Endocrinol. 2020, 11, 586529. [Google Scholar] [CrossRef]
- Golan, D.; Staun-Ram, E.; Glass-Marmor, L.; Lavi, I.; Rozenberg, O.; Dishon, S.; Barak, M.; Ish-Shalom, S.; Miller, A. The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis. Brain Behav. Immun. 2013, 32, 180–185. [Google Scholar] [CrossRef] [PubMed]
- Nair, R.; Maseeh, A. Vitamin D: The “sunshine” vitamin. J. Pharm. Pharmacother. 2012, 3, 118–126. [Google Scholar] [CrossRef]
- Dupuis, M.L.; Pagano, M.T.; Pierdominici, M.; Ortona, E. The role of vitamin D in autoimmune diseases: Could sex make the difference? Biol. Sex Differ. 2021, 12, 12. [Google Scholar] [CrossRef] [PubMed]
- Huiberts, L.M.; Smolders, C.H.J.K. Effects of vitamin D on mood and sleep in the healthy population: Interpretations from the serotonergic pathway. Sleep Med. Rev. 2021, 55, 101379. [Google Scholar] [CrossRef]
- Ghareghani, M.; Reiter, R.J.; Zibara, K.; Farhadi, N. Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway. Front. Immunol. 2018, 9, 2484. [Google Scholar] [CrossRef]
- Sears, B. Anti-inflammatory Diets. J. Am. Coll. Nutr. 2015, 34, 14–21. [Google Scholar] [CrossRef]
- Caesar, R.; Tremaroli, V.; Kovatcheva-Datchary, P.; Cani, P.D.; Bäckhed, F. Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling. Cell Metab. 2015, 22, 658–668. [Google Scholar] [CrossRef] [Green Version]
- Giuliani, C.; Bucci, I.; Di Santo, S.; Rossi, C.; Grassadonia, A.; Mariotti, M.; Piantelli, M.; Monaco, F.; Napolitano, G. Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells. PLoS ONE 2014, 9, e107936. [Google Scholar] [CrossRef]
- Mao, Q.Q.; Xu, X.Y.; Cao, S.Y.; Gan, R.Y.; Corke, H.; Beta, T.; Li, H.B. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe). Foods 2019, 8, 185. [Google Scholar] [CrossRef] [Green Version]
- Berbert, A.A.; Kondo, C.R.; Almendra, C.L.; Matsuo, T.; Dichi, I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 2005, 21, 131–136. [Google Scholar] [CrossRef]
- Thornley, S.; Tayler, R.; Sikaris, K. Sugar restriction: The evidence for a drug-free intervention to reduce cardiovascular disease risk. Intern. Med. J. 2012, 5, 46–58. [Google Scholar] [CrossRef] [PubMed]
- Shakoor, H.; Feehan, J.; Apostolopoulos, V.; Platat, C.; Al Dhaheri, A.S.; Ali, H.I.; Ismail, L.C.; Bosevski, M.; Stojanovska, L. Immunomodulatory Effects of Dietary Polyphenols. Nutrients 2021, 13, 728. [Google Scholar] [CrossRef] [PubMed]
- Maleki, S.J.; Crespo, J.F.; Cabanillas, B. Anti-inflammatory effects of flavonoids. Food Chem. 2019, 299, 125124. [Google Scholar] [CrossRef] [PubMed]
- Eliaz, I.; Raz, A. Pleiotropic Effects of Modified Citrus Pectin. Nutrients 2019, 11, 2619. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Candelli, M.; Franza, L.; Pignataro, G.; Ojetti, V.; Covino, M.; Piccioni, A.; Gasbarrini, A.; Franceschi, F. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. Int. J. Mol. Sci. 2021, 22, 6242. [Google Scholar] [CrossRef] [PubMed]
- Gordon, J.; Morley, J.E.; Hershman, J.M. Melatonin and the thyroid. Horm. Metab. Res. 1980, 12, 71–73. [Google Scholar] [CrossRef]
- Sun, T.C.; Liu, X.C.; Yang, S.H.; Song, L.L.; Zhou, S.J.; Deng, S.L.; Tian, L.; Cheng, L.Y. Melatonin Inhibits Oxidative Stress and Apoptosis in Cryopreserved Ovarian Tissues via Nrf2/HO-1 Signaling Pathway. Front. Mol. Biosci. 2020, 7, 163. [Google Scholar] [CrossRef]
- Bellipanni, G.; Bianchi, P.; Pierpaoli, W.; Bulian, D.; Ilyia, E. Effects of melatonin in perimenopausal and menopausal women: A randomized and placebo controlled study. Exp. Gerontol. 2001, 36, 297–310. [Google Scholar] [CrossRef]
- Clifford, T.; Howatson, G.; West, D.J.; Stevenson, E.J. The potential benefits of red beetroot supplementation in health and disease. Nutrients 2015, 7, 2801–2822. [Google Scholar] [CrossRef]
- Guan, Y.S.; He, Q. Plants Consumption and Liver Health. Evid Based Complement. Altern. Med. 2015, 2015, 824185. [Google Scholar] [CrossRef] [Green Version]
- Klimek-Szczykutowicz, M.; Szopa, A.; Ekiert, H. Citrus limon (Lemon) Phenomenon-A Review of the Chemistry, Pharmacological Properties, Applications in the Modern Pharmaceutical, Food, and Cosmetics Industries, and Biotechnological Studies. Plants 2020, 9, 119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kumar, N.; Neerajand, S.; Kumar, J. Functional Properties of Pomegranate (Punica granatum L.). Pharm. Innov. 2018, 7, 71–81. Available online: https://www.thepharmajournal.com/archives/2018/vol7issue10/PartB/7-9-41-419.pdf (accessed on 28 March 2022).
- Kawagishi, H.; Fukumoto, Y.; Hatakeyama, M.; He, P.; Arimoto, H.; Matsuzawa, T.; Arimoto, Y.; Suganuma, H.; Inakuma, T.; Sugiyama, K. Liver injury suppressing compounds from avocado (Persea americana). J. Agric. Food Chem. 2001, 49, 2215–2221. [Google Scholar] [CrossRef] [PubMed]
- Bhuyan, D.J.; Alsherbiny, M.A.; Perera, S.; Low, M.; Basu, A.; Devi, O.A.; Barooah, M.S.; Li, C.G.; Papoutsis, K. The Odyssey of Bioactive Compounds in Avocado (Persea americana) and Their Health Benefits. Antioxidants 2019, 8, 426. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eliaz, I.; Hotchkiss, A.T.; Fishman, M.L.; Rode, D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother. Res. 2006, 20, 859–864. [Google Scholar] [CrossRef] [PubMed]
- Prasad, S.; Aggarwal, B.B. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. In Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed.; Benzie, I.F.F., Wachtel-Galor, S., Eds.; CRC Press/Taylor & Francis: Boca Raton, FL, USA, 2011; Chapter 13. [Google Scholar]
- McAnulty, L.S.; Nieman, D.C.; Dumke, C.L.; Shooter, L.A.; Henson, D.A.; Utter, A.C.; Milne, G.; McAnulty, S.R. Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2.5 h of running. Appl. Physiol. Nutr Metab. 2011, 36, 976–984. [Google Scholar] [CrossRef] [PubMed]
- Sears, M.E. Chelation: Harnessing and enhancing heavy metal detoxification--a review. Sci. World J. 2013, 18, 219840. [Google Scholar] [CrossRef] [Green Version]
- Mashhadi, N.S.; Ghiasvand, R.; Askari, G.; Hariri, M.; Darvishi, L.; Mofid, M.R. Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: Review of current evidence. Int. J. Prev. Med. 2013, 1, S36–S42. [Google Scholar]
- Brent, G.A. Environmental exposures and autoimmune thyroid disease. Thyroid 2010, 20, 755–761. [Google Scholar] [CrossRef] [Green Version]
- Albuquerque, Y.M.L.; Silva, W.E.D.; Souza, F.A.L.; Teixeira, V.W.; Teixeira, Á.A.C. Melatonin on hypothyroidism and gonadal development in rats: A review. JBRA Assist. Report. 2020, 24, 498–506. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).